Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery

Journal of Controlled Release

Volumn 82, Issue 2-3, 2002, Pages 189-212

  Kabanov, Alexander V ^a   Batrakova, Elena V ^a   Alakhov, Valery Yu ^b  

^a NEBRASKA MEDICAL CENTER   (United States)

^b Supratek Pharma Inc   (Canada)

Author keywords

Block copolymers; Blood brain barrier; Cancer chemotherapy; Drug delivery; Gene therapy

Indexed keywords

COPOLYMER; POLOXAMER; DRUG CARRIER;

BLOOD BRAIN BARRIER; CANCER CELL; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG SENSITIZATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG TRANSPORT; GENE DELIVERY SYSTEM; HUMAN; MICELLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE; TARGET CELL; ANIMAL; CELL CULTURE; CHEMISTRY; GENE TRANSFER; MOUSE; TISSUE DISTRIBUTION;

ANIMALS; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; MICE; MICELLES; POLOXAMER; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0037151313     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00009-3     Document Type: Review

References (123)

1. Drug delivery and targeting
2. Block copolymers as drug carriers
3. Block copolymer micelles as long-circulating drug vehicles
4. Long circulating microparticulate drug carriers
5. Block copolymer micelles (microcontainers for drug targeting)
6. Site specific drug carriers: Polymeric micelles as high potential vehicles for biologically active molecules
7. Block copolymeric biotransport carriers as versatile vehicles for drug delivery
8. Soluble self-assembled block copolymers for drug delivery
9. Nano-engineering block copolymer aggregates for drug delivery
10. Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers
11. A review of block polymer surfactants
12. Perfluorochemicals as oxygen transport vehicles
13. Adjuvant formulations and their mode of action
14. Physical basis for poloxamer interactions
15. Targeting of colloids to lymph nodes: Influence of lymphatic physiology and colloidal characteristics
16. Use of nonionic block copolymers in vaccines and therapeutics
17. Block copolymers in pharmaceutics
18. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine
19. Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels
20. Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic (PEO-PPO-PEO) block copolymers
21. Phase diagrams and aggregation behavior of poly(oxyethylene)-poly(oxypropylene)-poly(oxyethylene) triblock copolymers in aqueous solutions
22. Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions
23. Interaction of ABA block copolymers with ionic surfactants in aqueous solution
24. Surface activity of poly(ethylene oxide)-block-poly(propylene oxide)-block-poly(ethylene oxide) copolymers
25. Temperature-dependent micellization in aqueous block copolymer solutions
26. Light scattering study on the effect of polymer composition on the structural properties of PEO-PPO-PEO micelles
27. Light-scattering study on the association behavior of triblock polymers of ethylene oxide and propylene oxide in aqueous solution
28. Anomalous micellization behavior and composition heterogeneity of a triblock ABA copolymer of (A) ethylene oxide and (B) propylene oxide in aqueous solution
29. Characterization of a PEO-PPO-PEO block copolymer system
30. Micelle and gel formation in a poly(ethylene oxide)/poly(propylene oxide)/poly(ethylene oxide) triblock copolymer in water solution: Dynamic and static light scattering and oscillatory shear measurements
31. Structural study on the micelle formation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer in aqueous solution
32. Characterization of a poly(ethylene oxide)-poly(propylene oxide) triblock copolymer (EO27-PO39-EO27) in aqueous solution
33. Scanning densitometric and calorimetric studies of poly(ethylene oxide)/poly(propylene oxide)/poly(ethylene oxide) triblock copolymers (poloxamers) in dilute aqueous solution
34. Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: Thermodynamics of copolymer association
35. Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes
36. Molecular modeling of micelle formation and solubilization in block copolymer micelles. 1. A self-consistent mean-field lattice theory
37. Molecular modeling of micelle formation and solubilization in block copolymer micelles. 2. Lattice theory for monomers with internal degrees of freedom
38. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells
39. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells
40. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solution. The influence of relative block size
41. Micellization of poly(ethylene oxide)-poly(propylene oxide) block copolymers in aqueous solution
42. Micellization of poly(ethylene oxide)-poly(propylene oxide) block copolymers in aqueous solution: Effect of polymer impurities
43. Block copolymer self-assembly in selective solvents: Theory of solubilization in spherical micelles
44. In vitro and in vivo availability of liposomes
45. Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: Influence of liposome characteristics
46. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice
47. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size
48. Uptake by hepatocytes and biliary excretion of intravenously administered polystyrene microspheres in rats
49. Temperature effects on structural properties of Pluronic P104 and F108 PEO-PPO-PEO block copolymer solutions
50. Scaling of rheological properties of hydrogels from associating polymers
51. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting
52. Pluronic micelles as a tool for low-molecular compound vector delivery into a cell: Effect of Staphylococcus aureus enterotoxin B on cell loading with micelle incorporated fluorescent dye
53. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer
54. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials
55. Pluronic P85 enhances the delivery of digoxin to the brain: In vitro and in vivo studies
56. Strong solubilization of small molecules by triblock-copolymer micelles in selective solvents
57. Solubilization of aromatic solutes in block copolymers
58. Comparison of solubilization of hydrocarbons in (PEO-PPO) diblock versus (PEO-PPO-PEO) triblock copolymer micelles
59. Partition coefficients and their uses
60. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: A fluorescence probe study
61. Volatility and solubilization of synthetic fragrances by pluronic P-85
62. Evaluation of partition coefficients of low molecular weight solutes between water and micelles of block copolymer of ethylene oxide based on dialysis kinetics and fluorescence spectroscopy
63. Detergent-induced solubilization of cytochrome c oxidase as detected in a novel reconstituted system
64. Aqueous two-phase systems containing self-associating block copolymers. Partitioning of hydrophilic and hydrophobic biomolecules
65. Transformation of water-soluble enzymes into membrane active form by chemical modification
66. Fatty acid acylated peroxidase as a model for the study of interactions of hydrophobically-modified proteins with mammalian cells
67. Use of conjugates of bovine serum albumin with poly(alkylene oxide)s for solubilization of riboflavin ester
68. Conjugates of proteins with block co-polymers of ethylene and propylene oxides
69. Micelles of amphiphilic block copolymers as vehicles for drug delivery
70. Analysis of micelle formation of an adriamycin-conjugated polyethylene glycol-poly(aspartic acid) block copolymer by gel permeation chromatography
71. Physical entrapment of adriamycin in AB block copolymer micelles
72. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti-cancer activity
73. Mechanisms of drug resistance in chemotherapy for urogenital carcinoma
74. Multidrug resistance-associated protein subfamily transporters and drug resistance
75. Elimination of P-gp-mediated multidrug resistance by solubilization in Pluronic micelles
76. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells
77. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
78. Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers
79. Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers
80. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution
81. Molecular mechanisms of multidrug resistance in cancer chemotherapy
82. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems
83. Functional intracellular P-glycoprotein
84. Defective acidification in human breast tumor cells and implications for chemotherapy
85. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein
86. Selective energy depletion and sensitization of multiple drug resistant cancer cells by Pluronic block copolymers
87. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion
88. The interaction of nonionic detergents with lipid bilayer membranes
89. Histamine release from human basophils by synthetic block co-polymers composed of polyoxyethylene and polyoxypropylene and synergy with immunologic and non-immunologic stimuli
90. + uptake by non-ionic detergents
91. Uncoupling of oxidative phosphorylation by fatty acids and detergents suppressed by ATP/ADP antiporter inhibitors
92. The influence of pluronics and their conjugates with proteins on the rate of oxygen consumption by liver mitochondria and thymus lymphocytes
93. Effect of a polymeric surfactant on electron transport in HL-60 cells
94. 32P]ATP
95. Interaction of tumor and normal blood cells with ethylene oxide and propylene oxide block copolymers
96. Mechanism of pluronic effect on p-glycoprotein efflux system in blood-brain barrier: Contributions of energy depletion and membrane fluidization
97. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells
98. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
99. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state
100. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system
101. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells
102. Physical conjugation of (tri-) block copolymers to liposomes toward the construction of sterically stabilized vesicle systems
103. The uses and properties of PEG-linked proteins
104. Molecular mechanisms of liposome and immunoliposome steric protection with polyethylene glycol: Theoretical and experimental proofs of the role of polymer chain flexibility
105. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
106. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells
107. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells
108. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump
109. Contribution of probenecid-sensitive anion transport processes at the brain capillary endothelium and choroid plexus to the efficient efflux of valproic acid from the central nervous system
110. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers
111. Endocytosis: An overview
112. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2)
113. Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein
114. Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymer
115. Direct gene transfer into mouse muscle in vivo
116. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle
117. Block copolymeric biotransport carriers as versatile vehicles for drug delivery
118. Plasmid delivery to muscle: Recent advances in polymer delivery systems
119. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle